FDA: Sun’s Caraco Can Resume Some Operations at Two Michigan Facilities

Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree. The decree relates specifically to production of Caraco’s heart failure drug carvedilol and antibiotic paramomycin.
Drug Industry Daily